glp 1 cardiovascular risk reduction GLP-1 Receptor Agonists in Heart Failure Management TrimRX | Cardiovascular Risks of

97 These new GLP-1 RAs, including dual and triple agonists, are now in Phase 3 trials, and the clinical use of more potent GLP-1 RAs with additional indications is expected

STAT-3 is a pleiotropic transcription factor that upon constitutive activation becomes oncogenic (141)

Quieting Food Noise: How GLP-1s and Mindfulness Rewire the Default Mode Network (DMN) and Reward Circuits

Jul 7th, 2025 Understanding and Managing Food Cravings Food cravings are driven by a combination of biological, psychological, and environmental factors, and managing them involves mindful eating, a balanced diet, stress reduction, and environment control to maintain overall health